These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18545986)

  • 1. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB; Eskow KL; Steiniger A; Klioueva A; Negron GE; Lormand L; Park JY; Bishop C
    Psychopharmacology (Berl); 2008 Jul; 199(1):99-108. PubMed ID: 18545986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.
    Bishop C; Krolewski DM; Eskow KL; Barnum CJ; Dupre KB; Deak T; Walker PD
    J Neurosci Res; 2009 May; 87(7):1645-58. PubMed ID: 19115412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 1A receptor agonist modulation of motor deficits and cortical oscillations by NMDA receptor interaction in parkinsonian rats.
    Jiang X; Liang P; Wang K; Jia J; Wang X
    Neuropharmacology; 2022 Feb; 203():108881. PubMed ID: 34785162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
    Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
    Dupre KB; Ostock CY; Eskow Jaunarajs KL; Button T; Savage LM; Wolf W; Bishop C
    Exp Neurol; 2011 Jun; 229(2):288-99. PubMed ID: 21352823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    Dupre KB; Ostock CY; George JA; Eskow Jaunarajs KL; Hueston CM; Bishop C
    ACS Chem Neurosci; 2013 May; 4(5):747-60. PubMed ID: 23496922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.
    Ostock CY; Dupre KB; Jaunarajs KL; Walters H; George J; Krolewski D; Walker PD; Bishop C
    Neuropharmacology; 2011 Sep; 61(4):753-60. PubMed ID: 21635907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Dupre KB; Eskow KL; Barnum CJ; Bishop C
    Neuropharmacology; 2008 Dec; 55(8):1321-8. PubMed ID: 18824001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H; Rylander D; Bimpisidis Z; Cenci MA
    Exp Neurol; 2013 Dec; 250():116-24. PubMed ID: 24029003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.
    Eskow KL; Dupre KB; Barnum CJ; Dickinson SO; Park JY; Bishop C
    Synapse; 2009 Jul; 63(7):610-20. PubMed ID: 19309758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Dupre KB; Cruz AV; McCoy AJ; Delaville C; Gerber CM; Eyring KW; Walters JR
    Neurobiol Dis; 2016 Feb; 86():1-15. PubMed ID: 26586558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM; Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Dell'isola R; Katzman AC; Bishop C
    Neuropharmacology; 2014 Feb; 77():1-8. PubMed ID: 24067924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Dupre KB; Eskow KL; Negron G; Bishop C
    Brain Res; 2007 Jul; 1158():135-43. PubMed ID: 17553470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the differential roles of striatal 5-HT
    Meadows SM; Chambers NE; Conti MM; Bossert SC; Tasber C; Sheena E; Varney M; Newman-Tancredi A; Bishop C
    Exp Neurol; 2017 Jun; 292():168-178. PubMed ID: 28342749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A; Li Q; Gardoni F; Marcello E; Qin C; Carlsson T; Kirik D; Di Luca M; Björklund A; Bezard E; Carta M
    Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal glutamate release in L-DOPA-induced dyskinetic animals.
    Nevalainen N; Lundblad M; Gerhardt GA; Strömberg I
    PLoS One; 2013; 8(2):e55706. PubMed ID: 23390548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.
    Barnum CJ; Eskow KL; Dupre K; Blandino P; Deak T; Bishop C
    Neuroscience; 2008 Sep; 156(1):30-41. PubMed ID: 18687386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.